SCHEMBL27735486

SCHEMBL27735486

Cc1cc(C)c2c(c1)NC(C=O)C(C)(C)O2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27590521 0.71 MEN1 (0.31) —
SCHEMBL27659878 0.67 PARP1 (0.37) —
SCHEMBL754728 0.66 BRD4 (0.38) —
SCHEMBL27701156 0.66 MAPT (0.31) —
SCHEMBL27721773 0.66 RET (0.31) —
SCHEMBL27735476 0.63 ALDH1A1 (0.39) —
SCHEMBL27774969 0.63 CNR2 (0.31) —
SCHEMBL27721875 0.63 MAPT (0.37) —
SCHEMBL4982347 0.62 KDM4E (0.33) —
SCHEMBL27344407 0.61 CA12 (0.36) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101379048-B Benzoxazines and related nitrogen-containing heterobicyclic compounds useful as mineralocorticoid receptor modulating agents MITSUBISHI TANABE PHARMA CORP 2012-03-21 — — CN disclosed
CN-101379048-A Benzo  oxazines and related nitrogen-containing heterobicyclic compounds useful as mineralocorticoid receptor modulating agents MITSUBISHI TANABE PHARMA CORP (JP) 2009-03-04 — — CN disclosed
Send feedback